GRPH

Graphite Bio (GRPH)

Graphite Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GRPH

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/09	07 : 17	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:GRPH	Graphite Bio Inc
2024/03/09	07 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GRPH	Graphite Bio Inc
2024/03/09	07 : 00	Business Wire	Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics	NASDAQ:GRPH	Graphite Bio Inc
2024/03/05	20 : 09	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:GRPH	Graphite Bio Inc
2024/03/05	20 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GRPH	Graphite Bio Inc
2024/02/28	06 : 11	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:GRPH	Graphite Bio Inc
2024/02/14	06 : 44	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:GRPH	Graphite Bio Inc
2024/02/10	07 : 23	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	NASDAQ:GRPH	Graphite Bio Inc
2024/02/06	06 : 57	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	NASDAQ:GRPH	Graphite Bio Inc
2024/02/06	06 : 31	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GRPH	Graphite Bio Inc
2023/12/27	06 : 37	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:GRPH	Graphite Bio Inc
2023/12/27	06 : 32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GRPH	Graphite Bio Inc
2023/12/07	06 : 57	Edgar (US Regulatory)	Form S-4 - Registration of securities, business combinations	NASDAQ:GRPH	Graphite Bio Inc
2023/11/16	07 : 23	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:GRPH	Graphite Bio Inc
2023/11/15	22 : 09	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:GRPH	Graphite Bio Inc
2023/11/15	22 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GRPH	Graphite Bio Inc
2023/11/15	21 : 00	Business Wire	LENZ Therapeutics and Graphite Bio Announce Merger Agreement	NASDAQ:GRPH	Graphite Bio Inc
2023/10/31	05 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GRPH	Graphite Bio Inc
2023/09/14	05 : 06	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:GRPH	Graphite Bio Inc
2023/08/24	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GRPH	Graphite Bio Inc
2023/08/15	06 : 04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GRPH	Graphite Bio Inc
2023/08/03	05 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GRPH	Graphite Bio Inc
2023/07/22	06 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GRPH	Graphite Bio Inc
2023/07/22	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GRPH	Graphite Bio Inc
2023/07/22	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GRPH	Graphite Bio Inc
2023/07/22	06 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GRPH	Graphite Bio Inc
2023/07/20	21 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GRPH	Graphite Bio Inc
2023/06/23	20 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GRPH	Graphite Bio Inc
2023/06/23	20 : 00	Business Wire	Graphite Bio Announces Departure of Chief Financial Officer	NASDAQ:GRPH	Graphite Bio Inc
2023/06/07	05 : 16	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:GRPH	Graphite Bio Inc